CGT GMP Anti-Human CD28 mAb Production - Miltenyi Supplier Options
Our cutting-edge product CGT Gmp Anti-Human Cd28 Mab is produced by T&L Biotechnology Co., Ltd. This monoclonal antibody is specifically designed for use in immunotherapy and immune checkpoint blockade. It has been developed to specifically target the CD28 receptor on human T cells, which plays a crucial role in T cell activation and regulation of immune responses, Our production process follows GMP guidelines to ensure the highest quality and purity of the antibody. Rigorous testing and quality control measures are implemented at each stage of the production to guarantee the consistency and reliability of the final product, The CGT Gmp Anti-Human Cd28 Mab is a valuable tool for researchers and pharmaceutical companies involved in the development of novel cancer treatments and autoimmune disease therapies. Its high specificity and potency make it an essential component for in vitro and in vivo studies of immune modulatory therapies, With T&L Biotechnology's expertise in antibody production and commitment to quality, you can trust that CGT Gmp Anti-Human Cd28 Mab will meet your research and development needs with excellence
- High-Quality Gmp-Grade Raw Materials
- CGT Gmp-Grade Raw Materials
- Cell therapy Gmp-Grade Raw Materials
- Custom Gmp-Compliant Reagents
- High-Quality Gmp-Compliant Reagents
- CGT Gmp-Compliant Reagents
- Cell therapy Gmp-Compliant Reagents
- Custom Car T Cell Therapy
- High-Quality Car T Cell Therapy
- CGT Car T Cell Therapy